logo-loader
viewOpyl Ltd

ShareRoot's MediaConsent platform validated by big-name partners and backers

ShareRoot (ASX:SRO) CEO Noah Abelson-Gertler speaks to Proactive Investors about the commencement of stage 2 beta testing on the Silicon Valley-based company's MediaConsent platform; developed as a solution for companies aiming to be compliant with data privacy regulations.

Stage 1 of beta testing has resulted in the platform becoming more flexible with wider-reaching potential applications, with individual features being packaged as widgets.

Stage 2 beta testing is now underway with two major partner agencies - Zig Marketing and Ludomade - that work with myriad big-name global brands.

"We believe that MediaConsent is positioned to succeed in this space and grab a chunk of the multi-billion dollar market that is privacy and data regulation, for consumers and companies alike, online... we are showing the results not only in interest in our beta platform, but also in the growth of our advisory board, and [our register]," says Abelson-Gertler.

Quick facts: Opyl Ltd

Price: 0.145 AUD

ASX:OPL
Market: ASX
Market Cap: $4.29 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Opyl Ltd named herein, including the promotion by the Company of Opyl Ltd in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Opyl is new name of digital health track company ShareRoot

Opyl Limited (ASX:OPL) chief executive officer Michelle Gallaher updates Proactive on the renaming of the global digital health track company formerly known as ShareRoot Ltd (ASX:SRO). This heralds the company’s entry into the rapidly expanding global digital health and artificial...

on 9/12/19

2 min read